These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES
EXCHANGE
ACT OF 1934
|
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES
EXCHANGE
ACT OF 1934
|
|
Delaware
|
11-1986657
|
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer Identification No.)
|
|
|
incorporation
or organization)
|
|
|
55
CHARLES LINDBERGH BLVD., MITCHEL FIELD, N.Y.
|
11553
|
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
Page
No.
|
|
|
|
|
|
|
|
|
Condensed
Consolidated Balance Sheets -
|
|
|
January
31, 2010 and April 30, 2009
|
3
|
|
Condensed
Consolidated Statements of Operations
|
|
|
Nine
Months Ended January 31, 2010 and 2009
|
4
|
|
Condensed
Consolidated Statements of Operations
|
|
|
Three
Months Ended January 31, 2010 and 2009
|
5
|
|
Condensed
Consolidated Statements of Cash Flows
|
|
|
Nine
Months Ended January 31, 2010 and 2009
|
6
|
|
Notes
to Condensed Consolidated Financial Statements
|
7-13
|
|
|
|
|
Financial
Condition and Results of Operations
|
13-19
|
|
|
19
|
|
|
19-20
|
|
|
|
|
|
20
|
|
Signatures
|
21
|
|
Exhibits
|
22-25
|
|
January
31,
|
April
30,
|
|||||||
|
2010
|
2009
|
|||||||
|
(UNAUDITED)
|
(AUDITED)
|
|||||||
|
(NOTE
A)
|
||||||||
|
(In
thousands except share data)
|
||||||||
|
ASSETS:
|
||||||||
|
Current
assets:
|
||||||||
|
Cash
and cash equivalents
|
$ | 6,504 | $ | 4,911 | ||||
|
Marketable
securities
|
10,408 | 9,998 | ||||||
|
Accounts
receivable, net of allowance for doubtful accounts of $285 at January 31,
2010 and April 30, 2009
|
9,924 | 10,775 | ||||||
|
Costs
and estimated earnings in excess of billings
|
2,667 | 2,193 | ||||||
|
Inventories
|
28,585 | 26,051 | ||||||
|
Income
taxes receivable and refundable
|
2,443 | 886 | ||||||
|
Prepaid
expenses and other
|
864 | 1,257 | ||||||
|
Total
current assets
|
61,395 | 56,071 | ||||||
|
Property,
plant and equipment, at cost, less accumulated depreciation and
amortization
|
7,016 | 7,961 | ||||||
|
Goodwill
and other intangible assets, net
|
218 | 218 | ||||||
|
Cash
surrender value of life insurance and cash held in trust
|
8,784 | 8,423 | ||||||
|
Investments
in and loans receivable from affiliates
|
3,516 | 4,430 | ||||||
|
Other
assets
|
817 | 817 | ||||||
|
Total
assets
|
$ | 81,746 | $ | 77,920 | ||||
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY:
|
||||||||
|
Current
liabilities:
|
||||||||
|
Short-term
credit obligations
|
$ | 243 | $ | 1,327 | ||||
|
Accounts
payable - trade
|
2,833 | 2,305 | ||||||
|
Accrued
liabilities and other
|
4,385 | 4,408 | ||||||
|
Total
current liabilities
|
7,461 | 8,040 | ||||||
|
Lease
obligation – noncurrent
|
511 | 684 | ||||||
|
Deferred
compensation
|
9,599 | 9,546 | ||||||
|
Other
liabilities
|
641 | 484 | ||||||
|
Total
liabilities
|
18,212 | 18,754 | ||||||
|
Stockholders’
equity:
|
||||||||
|
Preferred
stock - $1.00 par value
|
- | - | ||||||
|
Common
stock - $1.00 par value
|
9,164 | 9,164 | ||||||
|
Additional
paid-in capital
|
49,422 | 48,997 | ||||||
|
Retained
earnings
|
5,096 | 2,522 | ||||||
| 63,682 | 60,683 | |||||||
|
Common
stock reacquired and held in treasury -at cost, 976,487 shares at January
31, 2010 and 1,021,159 shares at April 30, 2009
|
(4,799 | ) | (4,972 | ) | ||||
|
Accumulated
other comprehensive income
|
4,651 | 3,455 | ||||||
|
Total
stockholders' equity
|
63,534 | 59,166 | ||||||
|
Total
liabilities and stockholders' equity
|
$ | 81,746 | $ | 77,920 | ||||
|
2010
|
2009
|
|||||||
|
(In
thousands except per share data)
|
||||||||
|
Revenues
|
$ | 36,360 | $ | 40,297 | ||||
|
Cost
of revenues
|
23,243 | 30,932 | ||||||
|
Gross
margin
|
13,117 | 9,365 | ||||||
|
Selling
and administrative expenses
|
7,948 | 8,797 | ||||||
|
Research
and development expense
|
3,954 | 3,068 | ||||||
|
Operating
income (loss)
|
1,215 | (2,500 | ) | |||||
|
Other
income (expense):
|
||||||||
|
Investment
income
|
400 | 526 | ||||||
|
Equity
loss
|
(151 | ) | (100 | ) | ||||
|
Impairment
of investment in affiliate
|
(550 | ) | - | |||||
|
Interest
expense
|
(103 | ) | (269 | ) | ||||
|
Other
(expense) income, net
|
(207 | ) | 80 | |||||
|
Income
(Loss) before benefit for income taxes
|
604 | (2,263 | ) | |||||
|
Benefit
for income taxes
|
(1,970 | ) | (696 | ) | ||||
|
Net
income (loss)
|
$ | 2,574 | $ | (1,567 | ) | |||
|
Net
income (loss) per common share
|
||||||||
|
Basic
|
$ | 0.31 | $ | (0.19 | ) | |||
|
Diluted
|
$ | 0.31 | $ | (0.19 | ) | |||
|
Weighted
average shares outstanding
|
||||||||
|
Basic
|
8,176,638 | 8,381,424 | ||||||
|
Diluted
|
8,197,367 | 8,381,424 | ||||||
|
2010
|
2009
|
|||||||
|
(In
thousands except per share data)
|
||||||||
|
Revenues
|
$ | 12,524 | $ | 13,208 | ||||
|
Cost
of revenues
|
8,102 | 9,749 | ||||||
|
Gross
margin
|
4,422 | 3,459 | ||||||
|
Selling
and administrative expenses
|
2,608 | 2,845 | ||||||
|
Research
and development expense
|
1,500 | 829 | ||||||
|
Operating
income (loss)
|
314 | (215 | ) | |||||
|
Other
income (expense):
|
||||||||
|
Investment
income
|
147 | 159 | ||||||
|
Equity
income
|
44 | 208 | ||||||
|
Impairment
of investment in affiliate
|
(350 | ) | - | |||||
|
Interest
expense
|
(25 | ) | (76 | ) | ||||
|
Other
(expense) income, net
|
(51 | ) | 4 | |||||
|
Income
before benefit for income taxes
|
79 | 80 | ||||||
|
Benefit
for income taxes
|
(1,970 | ) | (19 | ) | ||||
|
Net
income
|
$ | 2,049 | $ | 99 | ||||
|
Net
income per common share
|
||||||||
|
Basic
|
$ | 0.25 | $ | 0.01 | ||||
|
Diluted
|
$ | 0.25 | $ | 0.01 | ||||
|
Weighted
average shares outstanding
|
||||||||
|
Basic
|
8,184,627 | 8,097,899 | ||||||
|
Diluted
|
8,222,574 | 8,097,899 | ||||||
|
2010
|
2009
|
|||||||
|
(In
thousands)
|
||||||||
|
Cash
flows from operating activities:
|
||||||||
|
Net
income (loss)
|
$ | 2,574 | $ | (1,567 | ) | |||
|
Non-cash
(income) charges to earnings, net
|
3,844 | 3,717 | ||||||
|
Net
changes in operating assets and liabilities
|
(3,293 | ) | 3,184 | |||||
|
Net
cash provided by operating activities
|
3,125 | 5,334 | ||||||
|
Cash
flows from investing activities:
|
||||||||
|
Proceeds
from sale of marketable securities
|
500 | 1,036 | ||||||
|
Purchase
of marketable securities
|
- | (6,599 | ) | |||||
|
Receipt
of loan payment from affiliate
|
220 | - | ||||||
|
Purchase
of fixed assets
|
(517 | ) | (423 | ) | ||||
|
Net
cash provided by (used in) investing activities
|
203 | (5,986 | ) | |||||
|
Cash
flows from financing activities:
|
||||||||
|
Proceeds
from short-term credit obligations
|
- | 2,500 | ||||||
|
Debt
payments
|
(1,314 | ) | (6,663 | ) | ||||
|
Purchase
of stock for treasury
|
- | (3,106 | ) | |||||
|
Net
cash used in financing activities
|
(1,314 | ) | (7,269 | ) | ||||
|
Net
increase (decrease) in cash and cash equivalents before effect of exchange
rate changes
|
2,014 | (7,921 | ) | |||||
|
Effect
of exchange rate changes on cash and cash equivalents
|
(421 | ) | 166 | |||||
|
Net
increase (decrease) in cash and cash equivalents
|
1,593 | (7,755 | ) | |||||
|
Cash
and cash equivalents at beginning of period
|
4,911 | 11,029 | ||||||
|
Cash
and cash equivalents at end of period
|
$ | 6,504 | $ | 3,274 | ||||
|
Supplemental
disclosures of cash flow information:
|
||||||||
|
Cash
paid during the period for:
|
||||||||
|
Interest
|
$ | 103 | $ | 201 | ||||
|
Income
Taxes
|
- | - | ||||||
|
Nine months
|
Three months
|
|||||||||||||||
|
Periods
ended January 31,
|
||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Basic
EPS Shares outstanding
|
||||||||||||||||
|
(weighted
average)
|
8,176,638 | 8,381,424 | 8,184,627 | 8,097,899 | ||||||||||||
|
Effect
of Dilutive Securities
|
20,729 | *** | 37,947 | *** | ||||||||||||
|
Diluted
EPS Shares outstanding
|
8,197,367 | 8,381,424 | 8,222,574 | 8,097,899 | ||||||||||||
|
***
|
Dilutive
securities are excluded for the nine- and three-month periods ended
January 31, 2009 since the inclusion of such shares would be
antidilutive.
|
|
Nine months
|
Three months
|
|||||||||||||||
|
Periods
ended January 31,
|
||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Outstanding
Options excluded
|
1,347,775 | 1,073,719 | 1,066,775 | 1,073,719 | ||||||||||||
|
January 31, 2010
|
April 30, 2009
|
|||||||
|
(In
thousands)
|
||||||||
|
Raw
materials and Component parts
|
$ | 11,935 | $ | 12,542 | ||||
|
Work
in progress
|
14,163 | 10,613 | ||||||
|
Finished
Goods
|
2,487 | 2,896 | ||||||
| $ | 28,585 | $ | 26,051 | |||||
|
Nine months ended January
31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Net
income (loss)
|
$ | 2,574 | $ | (1,567 | ) | |||
|
Foreign
currency translation adjustment
|
596 | (854 | ) | |||||
|
Change
in market value of marketable securities
|
917 | (163 | ) | |||||
|
Deferred
tax effect of change in market value of marketable
securities
|
(317 | ) | 65 | |||||
|
Comprehensive
income (loss)
|
$ | 3,770 | $ | (2,519 | ) | |||
|
(1)
|
FEI-NY
– consists principally of precision time and frequency control products
used in three principal markets: communication satellites (both commercial
and U.S. Government-funded); terrestrial cellular telephone or other
ground-based telecommunication stations and other components and systems
for the U.S. military.
|
|
(2)
|
Gillam-FEI
- the Company’s Belgian subsidiary primarily sells wireline
synchronization and network management
systems.
|
|
(3)
|
FEI-Zyfer
- the products of the Company’s subsidiary incorporate Global Positioning
System (GPS) technologies into systems and subsystems for secure
communications, both government and commercial, and other locator
applications.
|
|
Nine months
|
Three months
|
|||||||||||||||
|
Periods
ended January 31,
|
||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenues:
|
||||||||||||||||
|
FEI-NY
|
$ | 21,382 | $ | 28,104 | $ | 7,368 | $ | 9,471 | ||||||||
|
Gillam-FEI
|
8,812 | 7,708 | 3,837 | 2,407 | ||||||||||||
|
FEI-Zyfer
|
8,742 | 6,243 | 1,914 | 2,116 | ||||||||||||
|
less
intersegment revenues
|
(2,576 | ) | (1,758 | ) | (595 | ) | (786 | ) | ||||||||
|
Consolidated
revenues
|
$ | 36,360 | $ | 40,297 | $ | 12,524 | $ | 13,208 | ||||||||
|
Operating
income (loss):
|
||||||||||||||||
|
FEI-NY
|
$ | 885 | $ | (1,748 | ) | $ | 261 | $ | 33 | |||||||
|
Gillam-FEI
|
377 | (55 | ) | 382 | (45 | ) | ||||||||||
|
FEI-Zyfer
|
229 | (419 | ) | (256 | ) | (137 | ) | |||||||||
|
Corporate
|
(276 | ) | (278 | ) | (73 | ) | (66 | ) | ||||||||
|
Consolidated
operating income (loss)
|
$ | 1,215 | $ | (2,500 | ) | $ | 314 | $ | (215 | ) | ||||||
|
January 31, 2010
|
April 30, 2009
|
|||||||
|
Identifiable
assets:
|
||||||||
|
FEI-NY
|
$ | 39,773 | $ | 39,658 | ||||
|
Gillam-FEI
|
20,333 | 17,615 | ||||||
|
FEI-Zyfer
|
5,720 | 8,672 | ||||||
|
less
intercompany balances
|
(16,613 | ) | (17,853 | ) | ||||
|
Corporate
|
32,533 | 29,828 | ||||||
|
Consolidated
Identifiable Assets
|
$ | 81,746 | $ | 77,920 | ||||
|
Nine months
|
Three months
|
|||||||||||||||
|
Periods
ended January 31,
|
||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(in
thousands)
|
||||||||||||||||
|
Purchases
from:
|
||||||||||||||||
|
Elcom
|
$ | 15 | $ | 249 | $ | 9 | $ | 136 | ||||||||
|
Morion
|
222 | 814 | 2 | 345 | ||||||||||||
|
Sales
to:
|
||||||||||||||||
|
Elcom
|
$ | 1 | $ | 62 | $ | 1 | $ | 37 | ||||||||
|
Morion
|
76 | 98 | 11 | 48 | ||||||||||||
|
Interest
on Elcom note receivable
|
$ | 69 | $ | 53 | $ | 45 | $ | 16 | ||||||||
|
January 31, 2010
|
||||||||||||||||
|
Gross
|
Gross
|
Fair
|
||||||||||||||
|
Unrealized
|
Unrealized
|
Market
|
||||||||||||||
|
Cost
|
Gains
|
Losses
|
Value
|
|||||||||||||
|
Fixed
income securities
|
$ | 9,658 | $ | 280 | $ | (136 | ) | $ | 9,802 | |||||||
|
Equity
securities
|
450 | 156 | - | 606 | ||||||||||||
| $ | 10,108 | $ | 436 | $ | (136 | ) | $ | 10,408 | ||||||||
|
April 30, 2009
|
||||||||||||||||
|
Gross
|
Gross
|
Fair
|
||||||||||||||
|
Unrealized
|
Unrealized
|
Market
|
||||||||||||||
|
Cost
|
Gains
|
Losses
|
Value
|
|||||||||||||
|
Fixed
income securities
|
$ | 10,165 | $ | 278 | $ | (803 | ) | $ | 9,640 | |||||||
|
Equity
securities
|
450 | - | (92 | ) | 358 | |||||||||||
| $ | 10,615 | $ | 278 | $ | (895 | ) | $ | 9,998 | ||||||||
|
Less than 12 months
|
12 Months or more
|
Total
|
||||||||||||||||||||||
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
|||||||||||||||||||
|
Value
|
Losses
|
Value
|
Losses
|
Value
|
Losses
|
|||||||||||||||||||
|
January 31, 2010
|
||||||||||||||||||||||||
|
Fixed
Income Securities
|
$ | - | $ | - | $ | 1,916 | $ | (136 | ) | $ | 1,916 | $ | (136 | ) | ||||||||||
|
Equity
Securities
|
- | - | - | - | - | - | ||||||||||||||||||
| $ | - | $ | - | $ | 1,916 | $ | (136 | ) | $ | 1,916 | $ | (136 | ) | |||||||||||
|
April 30, 2009
|
||||||||||||||||||||||||
|
Fixed
Income Securities
|
$ | - | $ | - | $ | 2,268 | $ | (803 | ) | $ | 2,268 | $ | (803 | ) | ||||||||||
|
Equity
Securities
|
- | - | 358 | (92 | ) | 358 | (92 | ) | ||||||||||||||||
| $ | - | $ | - | $ | 2,626 | $ | (895 | ) | $ | 2,626 | $ | (895 | ) | |||||||||||
|
Current
|
$ | - | ||
|
Due
after one year through five years
|
9,658 | |||
|
Due
after five years through ten years
|
- | |||
| $ | 9,658 |
|
|
Level
1
|
Inputs
to the valuation methodology are unadjusted quoted prices for identical
assets or liabilities in active markets that the Company has the ability
to access.
|
|
|
Level
2
|
Inputs
to the valuation methodology
include:
|
|
-
|
Quoted
prices for similar assets or liabilities in active
markets;
|
|
-
|
Quoted
prices for identical or similar assets or liabilities in inactive
markets
|
|
-
|
Inputs
other than quoted prices that are observable for the asset or
liability;
|
|
-
|
Inputs
that are derived principally from or corroborated by observable market
data by correlation or other
means.
|
|
|
Level
3
|
Inputs
to the valuation methodology are unobservable and significant to the fair
value measurement.
|
|
Nine months
|
Three months
|
|||||||||||||||
|
Periods ended January 31,
|
||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenues
|
||||||||||||||||
|
FEI-NY
|
58.8
|
%
|
69.7
|
%
|
58.8
|
%
|
71.7
|
%
|
||||||||
|
Gillam-FEI
|
24.2
|
19.1
|
30.6
|
18.2
|
||||||||||||
|
FEI-Zyfer
|
24.0
|
15.5
|
15.3
|
16.0
|
||||||||||||
|
Less
intersegment revenues
|
(7.0
|
)
|
(4.3
|
)
|
(4.7
|
)
|
(5.9
|
)
|
||||||||
|
100.0
|
100.0
|
100.0
|
100.0
|
|||||||||||||
|
Cost
of revenues
|
63.9
|
76.8
|
64.7
|
73.8
|
||||||||||||
|
Gross
Margin
|
36.1
|
23.2
|
35.3
|
26.2
|
||||||||||||
|
Selling
and administrative expenses
|
21.9
|
21.8
|
20.8
|
21.5
|
||||||||||||
|
Research
and development expenses
|
10.9
|
7.6
|
12.0
|
6.3
|
||||||||||||
|
Operating
Income (Loss)
|
3.3
|
(6.2
|
)
|
2.5
|
(1.6
|
)
|
||||||||||
|
Other
income (expense), net
|
(1.6
|
)
|
0.6
|
(1.9
|
)
|
2.2
|
||||||||||
|
Pretax
Income (Loss)
|
1.7
|
(5.6
|
)
|
0.6
|
0.6
|
|||||||||||
|
Benefit
for income taxes
|
(5.4
|
)
|
(1.7
|
)
|
(15.7
|
)
|
(0.1
|
)
|
||||||||
|
Net
Income (Loss)
|
7.1
|
%
|
(3.9
|
)%
|
16.3
|
%
|
0.7
|
%
|
||||||||
|
|
(in millions)
|
|||||||||||||||||||||||||||||||
|
Nine months
|
Three months
|
|||||||||||||||||||||||||||||||
|
Periods ended January 31,
|
||||||||||||||||||||||||||||||||
|
Segment
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||||||||||||||||||||||
|
FEI-NY
|
$ | 21.4 | $ | 28.1 | $ | (6.7 | ) | (24 | )% | $ | 7.4 | $ | 9.5 | $ | (2.1 | ) | (22 | )% | ||||||||||||||
|
Gillam-FEI
|
8.8 | 7.7 | 1.1 | 14 | % | 3.8 | 2.4 | 1.4 | 59 | % | ||||||||||||||||||||||
|
FEI-Zyfer
|
8.7 | 6.2 | 2.5 | 40 | % | 1.9 | 2.1 | (0.2 | ) | (10 | )% | |||||||||||||||||||||
|
Intersegment
revenues
|
(2.6 | ) | (1.7 | ) | (0.9 | ) | (0.6 | ) | (0.8 | ) | 0.2 | |||||||||||||||||||||
| $ | 36.3 | $ | 40.3 | $ | ( 4.0 | ) | (10 | )% | $ | 12.5 | $ | 13.2 | $ | ( 0.7 | ) | (5 | )% | |||||||||||||||
|
Nine months
|
Three months
|
|||||||||||||||||||||||||||||||
|
Periods ended January 31,
|
||||||||||||||||||||||||||||||||
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
|||||||||||||||||||||||||||
| $ | 13,117 | $ | 9,365 | $ | 3,752 | 40 | % | $ | 4,422 | $ | 3,459 | $ | 963 | 28 | % | |||||||||||||||||
|
GM
Rate
|
36.1 | % | 23.2 | % | 35.3 | % | 26.2 | % | ||||||||||||||||||||||||
|
Nine months
|
Three months
|
||||||||||||||||||||||||||||
|
Periods ended January 31,
|
|||||||||||||||||||||||||||||
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||||||||||||||||||||
|
$
|
7,948
|
$ | 8,797 | $ | (849 | ) | (10 | )% | $ | 2,608 | $ | 2,845 | $ | (237 | ) | (8 | )% | ||||||||||||
|
Nine months
|
Three months
|
||||||||||||||||||||||||||||
|
Periods ended January 31,
|
|||||||||||||||||||||||||||||
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||||||||||||||||||||
| $ |
3,954
|
$ | 3,068 | $ | 886 | 29 | % | $ | 1,500 | $ | 829 | $ | 671 | 81 | % | ||||||||||||||
|
Nine months
|
Three months
|
|||||||||||||||||||||||
|
Periods
ended January 31,
|
||||||||||||||||||||||||
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
|||||||||||||||||||
| $ |
1,215
|
$ | (2,500 | ) | $ | 3,715 |
NM
|
$ | 314 | $ | (215 | ) | $ | 529 |
NM
|
|||||||||
|
Nine months
|
Three months
|
|||||||||||||||||||||||||||||||
|
Periods ended January 31,
|
||||||||||||||||||||||||||||||||
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
|||||||||||||||||||||||||||
|
Investment
income
|
$ | 400 | $ | 526 | $ | (126 | ) | (24 | )% | $ | 147 | $ | 159 | $ | ( 12 | ) | (8 | )% | ||||||||||||||
|
Equity
(loss) income
|
(151 | ) | (100 | ) | (51 | ) | (51 | )% | 44 | 208 | (164 | ) | (79 | )% | ||||||||||||||||||
|
Impairment
charge
|
(550 | ) | - | (550 | ) |
NM
|
(350 | ) | - | (350 | ) |
NM
|
||||||||||||||||||||
|
Interest
expense
|
(103 | ) | (269 | ) | 166 | 62 | % | (25 | ) | (76 | ) | 51 | 67 | % | ||||||||||||||||||
|
Other
income, net
|
(207 | ) | 80 | (287 | ) |
NM
|
(51 | ) | 4 | (55 | ) |
NM
|
||||||||||||||||||||
| $ | ( 611 | ) | $ | 237 | $ | (848 | ) |
NM
|
$ | (235 | ) | $ | 295 | $ | (530 | ) |
NM
|
|||||||||||||||
|
Nine months
|
Three months
|
||||||||||||||||||||||||||
|
Periods ended January 31,
|
|||||||||||||||||||||||||||
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||||||||||||||||||
|
$
|
(1,970
|
) | $ | (696 | ) | $ | (1,274 | ) | 183 | % | $ | (1,970 | ) | $ | (19 | ) | $ | (1,951 | ) |
NM
|
|||||||
|
Nine months
|
Three months
|
|||||||||||||||||||||||
|
Periods ended January 31,
|
||||||||||||||||||||||||
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
|||||||||||||||||||
|
$
|
2,574
|
$ | (1,567 | ) | $ | 4,141 |
NM
|
$ | 2,049 | $ | 99 | $ | 1,950 |
NM
|
||||||||||
|
31.1
-
|
Certification
by the Chief Executive Officer
pursuant to
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as
adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
31.2
-
|
Certification
by the Chief Financial Officer
pursuant to
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as
adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
32.1
-
|
Certification
by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
|
32.2
-
|
Certification
by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
|
FREQUENCY
ELECTRONICS, INC.
|
||
|
(Registrant)
|
||
|
Date:
March 17, 2010
|
BY
|
/s/ Alan Miller
|
|
Alan Miller
|
||
|
Chief
Financial Officer and Treasurer
|
||
|
Signing
on behalf of the registrant and
as
principal financial
officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|